findmyKOL
Clinical trialNCT05955261SuspendedPhase 2Interventional

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

SponsorSt. Jude Children's Research HospitalEnrollment70Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Valley Children'S Hospital

    Madera, California, United States

  • Children'S Hospital of Orange County

    Orange, California, United States

  • Rady Children'S Hospital-San Diego

    San Diego, California, United States

  • Children'S National Medical Center

    Washington D.C., District of Columbia, United States

  • Ann & Robert H. Lurie Children'S Hospital

    Chicago, Illinois, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Novant Health Presbyterian Medical Center

    Charlotte, North Carolina, United States

  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

  • St. Jude Children'S Research Hospital

    Memphis, Tennessee, United States

  • Cook Children'S Medical Center

    Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jul 2023
Primary completion
31 Dec 2026
Completion
31 Mar 2034
Last update posted
23 Apr 2026
Registered enrollment
70
Registry id
NCT05955261

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.